Jurgen Schrenk

Title: Jurgen Schrenk: Innovator in Enzyme Immunoassays

Introduction

Jurgen Schrenk is a notable inventor based in Weilheim, Germany. He has made significant contributions to the field of enzyme immunoassays, holding a total of 5 patents. His work has advanced the methodologies used in the determination of antigens and haptens, showcasing his expertise and innovative spirit.

Latest Patents

One of Jurgen Schrenk's latest patents is focused on a homogeneous enzyme immunoassay with a heating step after incubation. This process allows for the determination of an antigen or hapten in a homogeneous aqueous phase by incubating it with antigen- or hapten-specific antibodies and a defined amount of enzyme-marked antigen or hapten. The method involves heating the reaction solution under specific temperature conditions to inactivate the marker enzyme by at least 50% in the absence of the specific antibody, followed by measuring the enzyme activity. Additionally, he has developed a reagent for this process, which includes a specific amount of β-galactosidase-hapten conjugate, hapten antibody, buffer (pH 6.0 to 8.5), and a system for determining β-galactosidase activity.

Career Highlights

Jurgen Schrenk is currently associated with Boehringer Mannheim GmbH, where he continues to innovate and contribute to the field of biochemistry. His work has been instrumental in enhancing the accuracy and efficiency of immunoassays, making significant impacts in medical diagnostics.

Collaborations

Throughout his career, Jurgen has collaborated with esteemed colleagues such as Peter Wunderwald and Hans Port. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Jurgen Schrenk's contributions to enzyme immunoassays exemplify his dedication to innovation in the field. His patents and ongoing work at Boehringer Mannheim GmbH continue to influence the landscape of biochemical research and diagnostics.